Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.520 | 1.520 | 0.000 |
Stocks | 98.480 | 98.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.304 | 21.717 |
Price to Book | 3.512 | 4.007 |
Price to Sales | 1.188 | 2.277 |
Price to Cash Flow | 14.193 | 16.973 |
Dividend Yield | 1.930 | 1.339 |
5 Years Earnings Growth | 8.645 | 11.138 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GSK plc DRC | US37733W2044 | 5.78 | 43.35 | +1.83% | |
Eli Lilly | US5324571083 | 5.25 | 755.91 | -2.68% | |
HCA | US40412C1018 | 5.14 | 308.84 | -0.19% | |
Sanofi | FR0000120578 | 5.05 | 91.90 | -1.27% | |
McKesson | US58155Q1031 | 4.66 | 530.27 | -0.16% | |
GE HealthCare | US36266G1076 | 4.44 | 77.83 | -0.55% | |
Novo Nordisk B | DK0062498333 | 4.24 | 873.1 | -2.74% | |
Pfizer | US7170811035 | 4.10 | 27.70 | +1.91% | |
Roche Holding Participation | CH0012032048 | 4.09 | 214.10 | -2.95% | |
Elevance Health | US0367521038 | 4.00 | 525.73 | +0.17% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fondsfinans Norden | 2.73B | 13.56 | 9.38 | - | ||
Fondsfinans Norge | 2.26B | 3.32 | 12.66 | 11.85 | ||
Fondsfinans Aktiv 60/40 | 324.28M | 5.87 | 6.93 | 8.49 | ||
Fondsfinans Global Energi | 184.81M | -2.44 | -6.79 | -2.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review